FAM225A and neoplasm: NETO2 was determined as a target of miR-206 and miR-143-5p, and participation of NETO2 tumor progression and angiogenesis through overexpression of lncRNA FAM225A absorbed miR-206 was revealed (Wada et al., 2020; Zhang et al., 2020).